https://www.selleckchem.com/products/bi-3231.html
1-8.3). 48.5% of patients remained on respiratory support at the time of death. Conclusions End-of-life care for patients with Covid-19 remains a challenge. Patients tend to be frail and comorbid with a rapid disease trajectory. Non-Invasive Respiratory Support may play a key role in symptom management in select patients, however, further work is needed in order to identify patients who will most benefit from Respiratory Support and those for whom withdrawal may prevent unnecessary distress at the end of life or potential prolongation o
Like
Comment
Share
